Predictors of Success of Adenoidectomy in the Treatment of Pediatric Chronic Rhinosinusitis.
Amani KaisNorman A OrabiRuifeng CuiHassan H RamadanPublished in: Ear, nose, & throat journal (2024)
Objectives: There is consensus for adenoidectomy as treatment of chronic rhinosinusitis (CRS) in children younger than 6 years but less consensus for those aged 6 years and older. The present clinical research study investigated predictors of adenoidectomy success for pediatric CRS. Methods: A retrospective chart review was conducted for 107 children who presented to an otolaryngology clinic and had an adenoidectomy for CRS after failure of maximal medical therapy. Results: The majority of sample was male (N = 63; 58.9%) with mean age of 4.88 (SD = 2.54) and mean Lund-Mackay score of 7.76 (SD = 3.87). Patients who had success with adenoidectomy were older on average [mean ( M ) = 5.46; SD = 2.83] than patients who failed the procedure ( M = 4.36; SD = 2.40; F = 4.06, P = .047). This equated to 67.9% of children aged 6 years and older and 39.2% of children younger than 6 years succeeding with the surgery. Conclusions: Adenoidectomy is a good first-line surgery for children aged 12 years and younger, especially in the 6 to 12 years group which had a high rate of success with 68% experiencing remission of symptoms after surgery.
Keyphrases
- young adults
- minimally invasive
- chronic rhinosinusitis
- physical activity
- stem cells
- middle aged
- coronary artery bypass
- rheumatoid arthritis
- community dwelling
- coronary artery disease
- mesenchymal stem cells
- percutaneous coronary intervention
- bone marrow
- atrial fibrillation
- clinical practice
- combination therapy
- atomic force microscopy
- replacement therapy